ATE186218T1 - Impfstoffzusammensetzungen fuer mukosale abgabe - Google Patents
Impfstoffzusammensetzungen fuer mukosale abgabeInfo
- Publication number
- ATE186218T1 ATE186218T1 AT93911878T AT93911878T ATE186218T1 AT E186218 T1 ATE186218 T1 AT E186218T1 AT 93911878 T AT93911878 T AT 93911878T AT 93911878 T AT93911878 T AT 93911878T AT E186218 T1 ATE186218 T1 AT E186218T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccine compositions
- tetanus
- mucosal surface
- provides
- pertussis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929209118A GB9209118D0 (en) | 1992-04-28 | 1992-04-28 | Vaccine compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE186218T1 true ATE186218T1 (de) | 1999-11-15 |
Family
ID=10714652
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98120803T ATE340589T1 (de) | 1992-04-28 | 1993-04-28 | Impfstoffzusammensetzungen für mukosale abgabe |
AT93911878T ATE186218T1 (de) | 1992-04-28 | 1993-04-28 | Impfstoffzusammensetzungen fuer mukosale abgabe |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98120803T ATE340589T1 (de) | 1992-04-28 | 1993-04-28 | Impfstoffzusammensetzungen für mukosale abgabe |
Country Status (11)
Country | Link |
---|---|
US (1) | US6562352B1 (de) |
EP (2) | EP0639081B1 (de) |
AT (2) | ATE340589T1 (de) |
AU (1) | AU4267093A (de) |
DE (2) | DE69326948T2 (de) |
DK (2) | DK0937462T3 (de) |
ES (2) | ES2141765T3 (de) |
GB (1) | GB9209118D0 (de) |
GR (1) | GR3032381T3 (de) |
PT (2) | PT937462E (de) |
WO (1) | WO1993021950A1 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197548B1 (en) | 1990-04-02 | 2001-03-06 | Medeva Pharma Limited | Transformed Pichia expressing the pertactin antigen |
US7214787B1 (en) * | 1993-09-21 | 2007-05-08 | United States Of America As Represented By The Secretary Of The Army | Recombinant vaccine against botulinum neurotoxin |
WO1997002835A1 (en) * | 1995-07-07 | 1997-01-30 | Oravax, Inc. | Intranasal vaccination against gastrointestinal disease |
GB9611501D0 (en) * | 1996-06-03 | 1996-08-07 | Smithkline Beecham Biolog | Vaccine compositions |
US6761888B1 (en) | 2000-05-26 | 2004-07-13 | Neuralab Limited | Passive immunization treatment of Alzheimer's disease |
US6710226B1 (en) | 1997-12-02 | 2004-03-23 | Neuralab Limited | Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics |
US6913745B1 (en) | 1997-12-02 | 2005-07-05 | Neuralab Limited | Passive immunization of Alzheimer's disease |
US6750324B1 (en) | 1997-12-02 | 2004-06-15 | Neuralab Limited | Humanized and chimeric N-terminal amyloid beta-antibodies |
US6743427B1 (en) | 1997-12-02 | 2004-06-01 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
US7790856B2 (en) | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US6787523B1 (en) | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
US6923964B1 (en) | 1997-12-02 | 2005-08-02 | Neuralab Limited | Active immunization of AScr for prion disorders |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
CA2341358C (en) * | 1998-09-01 | 2011-04-26 | David James Brayden | Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
AU5441199A (en) * | 1998-09-01 | 2000-03-21 | Elan Corporation, Plc | Oral vaccine compositions |
US7087236B1 (en) | 1998-09-01 | 2006-08-08 | Merrion Research I Limited | Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
US6787637B1 (en) | 1999-05-28 | 2004-09-07 | Neuralab Limited | N-Terminal amyloid-β antibodies |
UA81216C2 (en) | 1999-06-01 | 2007-12-25 | Prevention and treatment of amyloid disease | |
GB9923060D0 (en) * | 1999-09-29 | 1999-12-01 | Chiron Spa | Vaccine |
US6651655B1 (en) | 2000-01-18 | 2003-11-25 | Quadrant Technologies Limited | Inhaled vaccines |
US7700751B2 (en) | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
BR0214279A (pt) * | 2001-11-19 | 2005-12-20 | Becton Dickinson Co | Composições farmacêuticas em forma particulada |
MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
PE20050627A1 (es) | 2003-05-30 | 2005-08-10 | Wyeth Corp | Anticuerpos humanizados que reconocen el peptido beta amiloideo |
US8916165B2 (en) | 2004-12-15 | 2014-12-23 | Janssen Alzheimer Immunotherapy | Humanized Aβ antibodies for use in improving cognition |
US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
PL2182983T3 (pl) | 2007-07-27 | 2014-10-31 | Janssen Alzheimer Immunotherap | Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8516442D0 (en) * | 1985-06-28 | 1985-07-31 | Wellcome Found | Cloned antigen |
JPS632932A (ja) * | 1986-06-23 | 1988-01-07 | Teijin Ltd | 経鼻投与用粉末状組成物 |
EP0267998A1 (de) | 1986-11-17 | 1988-05-25 | Institut Pasteur | Mittel zur Unterstützung gegen Infektion und Vergiftung von Bordetella |
GB8910570D0 (en) * | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
GB8914122D0 (en) * | 1989-06-20 | 1989-08-09 | Wellcome Found | Polypeptide expression |
IT1248735B (it) * | 1990-06-21 | 1995-01-26 | Sclavo Spa | Vaccini acellulari contro la pertosse |
EP0484621A3 (en) * | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
PL170938B1 (pl) * | 1991-03-05 | 1997-02-28 | Wellcome Found | Sposób wytwarzania szczepionki przeciwko infekcjom Salmonella PL PL |
WO2006034129A2 (en) * | 2004-09-17 | 2006-03-30 | Jmar Research, Inc. | Systems and methods for detecting scattered light from a particle using illumination incident at an angle |
-
1992
- 1992-04-28 GB GB929209118A patent/GB9209118D0/en active Pending
-
1993
- 1993-04-28 AU AU42670/93A patent/AU4267093A/en not_active Abandoned
- 1993-04-28 PT PT98120803T patent/PT937462E/pt unknown
- 1993-04-28 AT AT98120803T patent/ATE340589T1/de not_active IP Right Cessation
- 1993-04-28 EP EP93911878A patent/EP0639081B1/de not_active Expired - Lifetime
- 1993-04-28 EP EP98120803A patent/EP0937462B1/de not_active Expired - Lifetime
- 1993-04-28 ES ES93911878T patent/ES2141765T3/es not_active Expired - Lifetime
- 1993-04-28 PT PT93911878T patent/PT639081E/pt unknown
- 1993-04-28 ES ES98120803T patent/ES2273391T3/es not_active Expired - Lifetime
- 1993-04-28 DK DK98120803T patent/DK0937462T3/da active
- 1993-04-28 DK DK93911878T patent/DK0639081T3/da active
- 1993-04-28 DE DE69326948T patent/DE69326948T2/de not_active Expired - Lifetime
- 1993-04-28 DE DE69334066T patent/DE69334066T2/de not_active Expired - Lifetime
- 1993-04-28 WO PCT/GB1993/000880 patent/WO1993021950A1/en active IP Right Grant
- 1993-04-28 AT AT93911878T patent/ATE186218T1/de not_active IP Right Cessation
-
1997
- 1997-10-28 US US08/963,129 patent/US6562352B1/en not_active Expired - Fee Related
-
2000
- 2000-01-14 GR GR20000400080T patent/GR3032381T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0639081T3 (da) | 2000-04-10 |
PT639081E (pt) | 2000-04-28 |
DE69326948T2 (de) | 2000-03-16 |
DE69334066D1 (de) | 2006-11-09 |
GR3032381T3 (en) | 2000-04-27 |
EP0937462A1 (de) | 1999-08-25 |
DE69326948D1 (de) | 1999-12-09 |
EP0937462B1 (de) | 2006-09-27 |
EP0639081B1 (de) | 1999-11-03 |
AU4267093A (en) | 1993-11-29 |
EP0639081A1 (de) | 1995-02-22 |
WO1993021950A1 (en) | 1993-11-11 |
PT937462E (pt) | 2007-01-31 |
ES2273391T3 (es) | 2007-05-01 |
GB9209118D0 (en) | 1992-06-10 |
DE69334066T2 (de) | 2007-05-03 |
DK0937462T3 (da) | 2007-01-29 |
ATE340589T1 (de) | 2006-10-15 |
ES2141765T3 (es) | 2000-04-01 |
US6562352B1 (en) | 2003-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69326948D1 (de) | Impfstoffzusammensetzungen fuer mukosale abgabe | |
JP3911058B2 (ja) | ストレプトコックス エキワクチン | |
FR16C0015I2 (fr) | Vaccins anticoquelucheux acellulaires et procedes de preparation correspondants | |
FI101632B1 (fi) | Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä | |
LU90203I2 (fr) | Anatoxine diphtérique anatoxine tétanique trois antigènes coquelucheux purifiés (toxine pertussique tp hémagglutinine filamenteuse (haf) et pertactine (protéine de membrane externe 69 kd) et le principal antigène de surface du virus de l'hépatite b (vhb) purfié (infanrix hepb) et ses dérivés pharmaceutiquement acceptables | |
LU91149I2 (fr) | Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et d'antigène de surface recombinant du virus d l'hépatite B(protéine S). | |
CY1110327T1 (el) | DTPa ΕΜΒΟΛΙΑ ΒΛΕΝΝΟΓΟΝΟΥ | |
DK0725653T3 (da) | Vaccinepræparater | |
EP1123711B1 (de) | Attenuierte Toxine als Adjuvantien | |
ATE258445T1 (de) | Impfstoff beinhaltend bacterin und toxoid aus pasteurella haemolytica typ a-1 | |
EP1490100B1 (de) | Kombinierte dns/protein impfstoffzusammensetzungen | |
RU2185852C1 (ru) | Способ вакцинопрофилактики дифтерии и столбняка на крайнем севере | |
WO1997046255A3 (en) | Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |